CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 387 enrolled
Drug / intervention
Azilsartandrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02100319
NCT02100319N/ACompleted
CompareCT.gov

Azilva Tablets Special Drug Use Surveillance "Hypertension Complicated by Diabetes "

Takeda·observational·Posted Mar 31, 2014·Updated Mar 21, 2019

In Brief

An observational study evaluating Azilsartan for Hypertension. Completed, enrolled 387 participants across 2 sites.

Detailed Summary

The purpose of this study is to evaluate the efficacy of azilsartan tablets (Azilva Tablets) in patients with hypertension complicated by diabetes mellitus whose blood pressure cannot be sufficiently reduced by monotherapy with angiotensin II receptor blockers (ARBs) other than azilsartan, in routine clinical practice

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsHypertension
CountriesJapan
Collaborators--

Timeline

N/ACompletedFinished
2014201520162017201820192020202120222023202420252026
First PostedMar 31, 2014
Enrollment StartMar 3, 2014
Primary CompletionFeb 29, 2016
TodayJul 2, 2026
Enrollment to primary: 2.0 yearsPosted 12.3 years ago

Interventions

Azilsartandrug

Azilsartan tablets